Related Experiment Video
Updated: Feb 10, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
Tian Fang1, Dan-Dan Liu2,3, He-Ming Ning2,3,4
1Department of Comparative Medicine, Jinling Hospital, Clinical School of Medical College of Nanjing University, Nanjing, 210002, China.
Abstract:
Modified citrus pectin (MCP) is a carbohydrate enriched complex, which has been implicated in cancer treatment and prevention. However, the effects of MCP on urinary bladder cancer (UBC) are unknown. In this study, MCP was first tested in T24 and J82 human UBC cells and showed the inhibition of cell viability by the sulforhodamine B (SRB) assay. The MCP-treated UBC cells exhibited G2/M phase arrest with the decrease of Cyclin B1 and phosphorylated Cdc2. Caspase-3 was also activated, leading to the cleavage of Caspase-3 and PARP. We further explored the possible molecular mechanisms upon MCP treatment in UBC cells. Reduction of galectin-3 was observed and followed with the inactivation of Akt signaling pathway. Of note, galectin-3 knockdown by RNA interference recapitulated the MCP-mediated anti-proliferation, cell cycle arrest and apoptosis. Moreover, oral administration of MCP to the T24 xenograft-bearing nude mice inhibited the tumor growth significantly (P < 0.05). Quantification analysis of immunohistochemistry staining for Ki67 and cleaved Caspase-3 confirmed the decrease of proliferation index (P < 0.05) and the increase of apoptosis index (P < 0.01) in 700 mg/kg MCP-fed UBC xenografts. Using the information from TCGA database, we revealed that the overexpression of galectin-3 was associated with high tumor grade with lymph node metastasis, poor overall survival in UBC patients. Considering the remarkable inhibitory effects of MCP on UBC cell proliferation and survival in vitro and in vivo mainly through galectin-3, which is upregulated in UBCs, MCP may become an attractive agent, as a natural dietary fiber, for prevention and therapy of UBCs.
Insights
Modified citrus pectin (MCP) shows promise in treating and preventing urinary bladder cancer (UBC). This natural dietary fiber inhibits UBC cell growth and survival by targeting galectin-3, offering a potential therapeutic agent.
Area of Science:
- Oncology
- Nutritional Science
- Molecular Biology
Background:
- Modified citrus pectin (MCP) is recognized for its potential in cancer treatment and prevention.
- The specific effects of MCP on urinary bladder cancer (UBC) remain largely unexplored.
Purpose of the Study:
- To investigate the efficacy of MCP in inhibiting human UBC cell lines and xenograft tumor growth.
- To elucidate the underlying molecular mechanisms of MCP's anti-cancer effects in UBC, focusing on galectin-3 and associated signaling pathways.
Main Methods:
- In vitro studies utilized T24 and J82 human UBC cells to assess cell viability, cell cycle progression, apoptosis, and molecular targets (galectin-3, Akt pathway).
- In vivo efficacy was evaluated in T24 xenograft-bearing nude mice treated with MCP, with tumor growth and cellular markers (Ki67, cleaved Caspase-3) analyzed.
- TCGA database analysis correlated galectin-3 expression with UBC patient outcomes.
Main Results:
- MCP significantly inhibited UBC cell viability, induced G2/M phase arrest, and promoted apoptosis by activating Caspase-3 and cleaving PARP.
- MCP treatment led to reduced galectin-3 expression and inactivation of the Akt signaling pathway.
- Galectin-3 knockdown mimicked MCP's anti-proliferative and pro-apoptotic effects.
- In vivo, MCP administration suppressed tumor growth, decreased proliferation (Ki67), and increased apoptosis (cleaved Caspase-3) in UBC xenografts.
- Overexpression of galectin-3 in UBC patients correlated with advanced tumor grade, lymph node metastasis, and poorer survival.
Conclusions:
- Modified citrus pectin demonstrates significant anti-cancer properties against urinary bladder cancer in vitro and in vivo.
- The anti-tumor effects of MCP are mediated, at least in part, through the downregulation of galectin-3 and subsequent modulation of the Akt pathway.
- Given its efficacy and the crucial role of galectin-3 in UBC progression, MCP presents a promising natural agent for UBC prevention and therapy.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Feedback Inhibition
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Enzyme Inhibition
Population Growth
Primary and Secondary Growth in Roots and Shoots

